yea what he said billiam..yall aint ready
yea what he said billiam..yall aint ready
"Drop 5 stacks on the makeup bag"
we are here....where joo!??!?!
HUH HUH
YEAH
no... you aint the ready... me and Bill have entrance music to pump us up... what now,... here it is... OUR FUCKING EPIC THEME MUSIC... yes it's a repost, but I enjoy the fuck outta this song... get over it...lolol
http://www.youtube.com/watch?v=XOLgBgnnUUE
you really don't want any after we listen to this... fighting, fucking, racing, anything. we be the shit at it.. no homo on the fucking part..
Originally Posted by PURP
To bad youtube is blocked at work, so i guess you fail. your music sucks anyway! i have music to pump me up to...its called spice girls..
I wanna make you holler
Imagine us together
Don't be afraid to play my game
Why don't you hesitate
I won't keep waiting for you
To come on let me take
You to my fantasy room
You gonna like it there
And all the things that I do
I'll treat you right
All through the night
"Drop 5 stacks on the makeup bag"
Morning bitches..
WTF is going on at Ford seriously?? They are making MONEY.. OMG
Before the bell: Futures higher after Ford's surprise profit, ahead of data
U.S. stock futures rose on Thursday morning after Ford reported a surprise earnings and following some mergers-and-acquisition activity. Another fresh wave of earnings releases awaits investors today, as well as jobless, homes data.
Ford Motor Co. (NYSE: F) surprised Wall Street this morning when it posted a profit in the second-quarter of $2.3 billion due mainly to a huge gain for debt reduction. While Ford would have reported a loss of $424 million, or 21 cents per share, without special items, the loss is still far smaller than the 50 cents analysts had expected.
That means your work is fail.... duh... and our music is the shit... plus you can't stereotype music by it's genres. Music is music. you have to respect it all or you're a music listnening to poser... lolol
that song makes me feel like i could fuck some shit up! LOL
haha, yeah my work is fail, atleast I have IA still. You must not have liked my spice girls. I will take it somewhere else. jerkface!
"Drop 5 stacks on the makeup bag"
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO!!!
HE DONE TOLD YOU TIFF!! OOOOOOOOOOOOOOOOOOOOOOOOOOo
ohhhhh yeahhhhhh...
I’ma hit you from the back, I’ma hit you from the,
I’ma hit you from the back, I’ma hit you from the,
I’ma hit you from the back, I’ma hit you from the,
I’ma hit you from the back and make you holler ‘til you pass out.
Holler back, holler back. (X4)
If you gots a neat stash (give me half, give me half)
And if you roll up on some cash (give me half, give me half)
And if your mumma’s in the back (give me half, give me half)
And you know I got the bass bat, bass bat, bass bat,
Bitches on the dick, give ‘em 3oh!3,
Poppin’ motherfuckers like ‘you know me’
Shining in the club with the goatee,
Rollin’ on the dubs like an OG.
Get them hands cracking in the 3oh!3
Hey yeah, shake-shake your ass now,
I’ma hit you from the back and make you holler ‘til you pass out.
Bang bang, bang bang, motherfucking street slang.
Is it getting hot in here or is it just me?
Is it getting hot in here or is it 3oh!3?
You’s a punk bitch if you don’t know bout Boulder,
Your girl’s a freak, cos that’s what I told her,
You think you’re tight, but my ice gets colder,
In Baller-ado fight you with my soldiers,
You know we clean, never smokin’ that doja,
The gang sign, cos that’s what we all love.
Hey yeah, shake-shake your ass now,
I’ma hit you from the back and make you holler ‘til you pass out.
Bang bang, bang bang, motherfucking street slang.
Is it getting hot in here or is it just me?
Is it getting hot in here or is it 3oh!3?
And we're off!!
Dow
8,897.73 +16.47 (0.19%)
S&P 500
955.64 +1.57 (0.16%)
Nasdaq
1,928.07 +1.69 (0.09%)
Germany's Wulff: Qatar To Take 17% Stake In Volkswagen
* Article
* Printer
Friendly
* Share:
Yahoo Buzz ↓ More
o facebook
o MySpace
o LinkedIn
o Digg
o del.icio.us
o NewsVine
o StumbleUpon
o Mixx
* smaller Text larger
FRANKFURT (Dow Jones)--The governor of the German state of Lower Saxony, Christian Wulff, Thursday said Qatar Investment Authority will take a 17% stake in Volkswagen AG (VOW.XE).
He added that the supervisory board of Europe's largest carmaker will make a decision about forming an integrated car manufacturing company with Porsche Automobil Holding SE (PAH3.XE) at a meeting Aug. 13.
Wulff said the full combination of Volkswagen and Porsche is expected to be completed in mid-2011.
Lower Saxony owns a 20.1% stake in Volkswagen, making it its second largest shareholder behind Porsche, which owns around 51% of Volkswagen ordinary shares and has options to purchase a further stake of around 20%.
Earlier Thursday, a person familiar with the negotiations said Qatar will acquire the stake in Volkswagen by acquiring share options held by Porsche.
Volkswagen and Porsche have been locked in a power struggle since Porsche's attempt to gain full control over its much larger German peer backfired when credit markets turned anemic amid the financial crisis, leaving the sportscar maker heavily indebted with around EUR10 billion in debt.
look here you little cumdumpsters! blah lol
"Drop 5 stacks on the makeup bag"
LOL
that's wack y0
just kidding....lol... I love haters also.. I have a shit ton of them....
Getting pumped for Rise Against tonight.. leaving here in 2 hours!!!!
Dow
8,923.58 +42.32 (0.48%)
S&P 500
958.41 +4.34 (0.45%)
Nasdaq
1,934.07 +7.69 (0.40%)
HI HATER!
"Drop 5 stacks on the makeup bag"
bye hater
i still wub joo.
"Drop 5 stacks on the makeup bag"
+1:idb:
awwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwww i wub joo to.
"Drop 5 stacks on the makeup bag"
DO WANT..
An absolutely crazy bullish chart. I will explain for those that are interested.
Bill i wub joo.
"Drop 5 stacks on the makeup bag"
We're going to break 9000 today!! Fuck ya..
Dow
8,979.05 +97.79 (1.10%)
S&P 500
965.34 +11.27 (1.18%)
Nasdaq
1,951.16 +24.78 (1.29%
DID I NOT SAY THAT EARLIER IN THE WEEK?? wow I'm good.
HI!
HI!
"Drop 5 stacks on the makeup bag"
I'm going to take a nap.... holla....
aww you want me to tuck you in and give you my teddy bear?
"Drop 5 stacks on the makeup bag"
WOW To the MOON!!!
Dow
9,010.34 +129.08 (1.45%)
S&P 500
968.53 +14.46 (1.52%)
Nasdaq
1,954.40 +28.02 (1.45%)
Bristol-Myers Buys Medarex Drugmaker for $2.4 Billion (Update2)
Share | Email | Print | A A A
By Tom Randall
July 23 (Bloomberg) -- Bristol-Myers Squibb Co. said it agreed to buy Medarex Inc. for about $2.4 billion to double its pipeline of experimental biological drugs, including one nearing U.S. approval for skin cancer.
Bristol-Myers will pay $16 a share, a 90 percent premium over yesterday’s closing price of $8.40 a share for Princeton, New Jersey-based Medarex, the companies said in a statement. Medarex has about $300 million in cash and securities that reduces the price to about $2.1 billion, Bristol-Myers said. Both boards agreed to the deal, the statement said.
The New York-based drugmaker is acquiring companies and forming partnerships to find new products to offset losses from Plavix, its top-selling medicine, when the anti-clotting drug faces generic competition in 2012. The deal gives Bristol-Myers full ownership of the skin-cancer drug ipilimumab, which it had been developing jointly with Medarex.
“If melanoma success is achieved, we believe the deal will seem particularly, and strategically, smart,” said Catherine Arnold, an analyst at Credit Suisse in New York. “The acquisition of Medarex provides Bristol-Myers with new capabilities and future royalty streams.”
Bristol-Myers said it will pay for the acquisition with cash, and the companies expect to close the deal in about 30 days. Bristol-Myers had about $9 billion in cash as of June 30, according to the company.
Bristol-Myers rose 10 cents, or 1 percent, to $20.50 at 9:54 a.m. in New York Stock Exchange composite trading. Medarex soared 89 percent, or $7.46, to $15.86 in Nasdaq trading.
‘Important Step’
“This is a strategic buy for Bristol to strengthen the biotech business,” Mitsuo Ohmi, a Tokyo-based health-care analyst at Japan Advisory LLC, said today in a telephone interview. “The premium looks high but it’s a great deal for what Bristol is getting in the long run. It will take some time to see an earnings contribution from the takeover.”
Cornelius also has been eliminating jobs and outsourcing research to meet a goal of reducing costs at Bristol-Myers by $2.5 billion in the next three years.
Ipilimumab, an experimental drug for metastatic melanoma, is in the third and final stage of testing typically required for U.S. Food and Drug Administration approval. The drug is also being studied in lung and prostate cancers.
Last month, Medarex shares jumped 13 percent after the Mayo Clinic said three prostate cancer patients who received ipilimumab are now cancer-free. Doctors reported the drug, in combination with other treatments, helped kill prostate cancer cells and shrink the tumors in the patients, allowing surgery.
Experimental Treatments
Bristol-Myers will gain rights to seven experimental antibodies owned by Medarex and stakes in three more drugs shared by the company, according to the statement. It will also acquire Medarex’s drug-development technology, used to find new ways to treat cancer and immunology disorders.
“Medarex’s technology platform, people and pipeline provide a strong component to our company’s biologics strategy, specifically immuno-oncology,” James M. Cornelius, Bristol- Myers chief executive officer, said in the statement. “This acquisition is another important step in our biopharma transformation.”
Cornelius’s strategy contrasts with mergers carried out by some of Bristol-Myers’ rival drugmakers. New York-based Pfizer Inc. is purchasing Wyeth of Madison, New Jersey, in a deal valued at $66 billion. Merck & Co., based in Whitehouse Station, New Jersey, is taking over Schering-Plough Corp. of Kenilworth, New Jersey, for about $46 billion.
“When you look at a company like Medarex, it really ticks all of the boxes in what we’re looking for,” Brian Henry, a spokesman for Bristol-Myers, said in a telephone interview. It matches Cornelius’s “string of pearls” of increasing the company’s focus on biological drugs through strategic acquisitions in oncology and immunology, Henry said.
“The number of biologics in our pipeline almost doubled in this deal,” Henry said. The companies have been in discussions “for a few months,” he said.
Bristol today said second-quarter profit from continuing operations rose 36 percent, topping analysts’ estimates, as the company eliminated jobs and sold more of its mood-stabilizing drug Abilify and Plavix blood thinner. Sales rose 3.5 percent to $5.38 billion.
Nicole Ochsner, a spokeswoman for Medarex, didn’t return a phone call for comment.
JPMorgan Chase is financial adviser for Bristol-Myers on the deal, and Cravath, Swaine & Moore LLP represents them. Medarex is advised by Goldman Sachs and represented by Covington & Burling LLP.
To contact the reporter on this story: Tom Randall in New York at
awwwwwwwwwwwwwwwwwww
"Drop 5 stacks on the makeup bag"
Posting Permissions
Reply With Quote
